3279 related articles for article (PubMed ID: 18021578)
1. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
[TBL] [Abstract][Full Text] [Related]
3. [Guidelines of treatment for bleeding peptic ulcer disease].
Chung IK; Lee DH; Kim HU; Sung IK; Kim JH; ;
Korean J Gastroenterol; 2009 Nov; 54(5):298-308. PubMed ID: 19934611
[TBL] [Abstract][Full Text] [Related]
4. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
[TBL] [Abstract][Full Text] [Related]
6. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
[TBL] [Abstract][Full Text] [Related]
7. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
9. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
10. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
El-Serag HB; Graham DY; Richardson P; Inadomi JM
Arch Intern Med; 2002 Oct; 162(18):2105-10. PubMed ID: 12374519
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Kanno T; Yuan Y; Tse F; Howden CW; Moayyedi P; Leontiadis GI
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD005415. PubMed ID: 34995368
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
13. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
14. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
[TBL] [Abstract][Full Text] [Related]
15. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
Zullo A; Hassan C; Campo SM; Morini S
Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Sreedharan A; Martin J; Leontiadis GI; Dorward S; Howden CW; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD005415. PubMed ID: 20614440
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG
Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696
[TBL] [Abstract][Full Text] [Related]
19. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M
Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
